Acid suppression in gastro-oesophageal reflux disease: Why? How? How much and when?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12185218.
- Also identified by PMC identifier 1742452.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
For patients with suboptimal relief from lifestyle modifications, acid suppressive therapy remains a cornerstone of treatment for gastro-oesophageal reflux disease (GORD). While a great deal of attention is focused on complications of GORD, adequate symptom relief remains an important and practical therapeutic goal. Adequate symptom relief is an achievable and easily measurable endpoint that both restores quality of life and prevents many potential complications.
Medical subject headings
- Anti-Ulcer Agents
- Gastroesophageal Reflux
- Histamine H2 Antagonists